Skip to main content
2024-03-26 18:00
Notice to attend the Annual General Meeting of Vitrolife AB (publ)
2024-02-02 08:00
Fourth quarter and full year report, 2023: Continued growth with margin expansions
2024-01-24 13:00
Conference call full year report 2023
2024-01-23 20:00
Vitrolife Group makes an impairment charge of SEK 4.3 billion relating to Igenomix and provides preliminary financials for the fourth quarter 2023
2023-12-12 10:00
Vitrolife Group unveils new corporate strategy and updates long-term financial objectives at Capital Markets Day
2023-11-30 15:00
Vitrolife Group to host Capital Markets Day on 12 December 2023
2023-10-27 08:00
Interim report Q3, 2023: Profitable growth globally despite headwind in the U.S.
2023-10-13 09:00
Conference call interim report
2023-10-05 16:30
Election committee for Vitrolife AB (publ)
2023-09-14 14:00
CEO has purchased shares in Vitrolife AB

Pagination

  • First page «
  • Previous page ‹‹
  • …
  • Page 2
  • Page 3
  • Current page 4
  • Page 5
  • Page 6
  • Page 7
  • …
  • Next page ››
  • Last page »